Singapore markets closed

Aadi Bioscience, Inc. (AADI)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
12.530.00 (0.00%)
At close: 04:00PM EST
12.53 0.00 (0.00%)
After hours: 04:15PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-35.78%
S&P500 52-week change 3-7.75%
52-week high 321.15
52-week low 311.00
50-day moving average 312.81
200-day moving average 313.36

Share statistics

Avg vol (3-month) 381.54k
Avg vol (10-day) 371.7k
Shares outstanding 524.4M
Implied shares outstanding 6N/A
Float 815.64M
% held by insiders 111.64%
% held by institutions 163.41%
Shares short (12 Jan 2023) 41.04M
Short ratio (12 Jan 2023) 412.04
Short % of float (12 Jan 2023) 45.82%
Short % of shares outstanding (12 Jan 2023) 44.25%
Shares short (prior month 14 Dec 2022) 41.05M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:15
Last split date 326 Aug 2021

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022


Profit margin 0.00%
Operating margin (ttm)-540.81%

Management effectiveness

Return on assets (ttm)-20.47%
Return on equity (ttm)-39.12%

Income statement

Revenue (ttm)10.99M
Revenue per share (ttm)0.52
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)-18.55M
EBITDA -59.28M
Net income avi to common (ttm)-62.59M
Diluted EPS (ttm)4.76
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)183.01M
Total cash per share (mrq)7.5
Total debt (mrq)1.72M
Total debt/equity (mrq)1.02
Current ratio (mrq)10.61
Book value per share (mrq)6.93

Cash flow statement

Operating cash flow (ttm)-50.76M
Levered free cash flow (ttm)-29.68M